Stay updated on SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Sign up to get notified when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.

Latest updates to the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new Locations section is added and shows Shandong as a study site, replacing the previous Shandong Locations entry. The HHS Vulnerability Disclosure link is removed and the page revision tag is updated to v3.3.3.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe update is a minor revision label change (added Revision: v3.3.2, removed v3.2.0) and does not modify study details, eligibility criteria, outcomes, or schedule. There are no changes to the core content or purpose of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedThe notice about government funding and NIH operating status was removed from the page.SummaryDifference0.4%

- Check66 days agoChange DetectedThe new screenshot shows minor visual and layout updates with no changes to core study information (title, conditions, eligibility criteria, or outcome measures).SummaryDifference0.4%

- Check95 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0), while removing the previous version tag (v3.1.0). The page now informs users about potential delays and where to check official status.SummaryDifference4%

- Check102 days agoChange DetectedUpdate: version bumped to v3.1.0 and new contact details added (email and phone). Removed: previous version label v3.0.2.SummaryDifference0.1%

Stay in the know with updates to SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.